CMS CAMERON MCKENNA NABARRO OLSWANG LLP
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Theatrical Producers (Except Motion Picture) and Miscellaneous Theatrical Services, Health and Allied Services, Not Elsewhere Classified, Legal Services, Individual and Family Social Services), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about CMS CAMERON MCKENNA NABARRO OLSWANG LLP
Live alerts from global media, monitored by Business Radar
2024-12-12 (medscape.com)
Could Paying for Obesity Medications Offset Obesity Care Costs?
With the Biden administration pushing for Medicare, Medicaid coverage of GLP-1s, analysts disagree on whether it will decrease obesity costs.
Read more
2024-12-12 (medscape.com)
Could Paying for Obesity Medications Offset Obesity Care Costs?
With the Biden administration pushing for Medicare, Medicaid coverage of GLP-1s, analysts disagree on whether it will decrease obesity costs.
Read more
2024-09-17 (pharmaphorum.com)
The critical importance of payer-provider collaboration goes beyond prior authorisation
This article discusses the critical importance of payer-provider collaboration in the Medicare system, highlighting its impact beyond prior authorisation processes. Learn more about how collaboration between payers and providers can improve patient outcomes and streamline healthcare delivery.
Read more
2024-08-29 (pharmaceutical-technology.com)
US negotiations for first round of drugs reveal $6bn in Medicare savings
The Biden Administration had announced the price cuts negotiated by the CMS for the first ten selected drugs as part of the Medicare price negotiations under the Inflation Reduction Act.
Read more
2024-08-29 (pharmaceutical-technology.com)
US negotiations for first round of drugs reveal $6bn in Medicare savings
The Biden Administration had announced the price cuts negotiated by the CMS for the first ten selected drugs as part of the Medicare price negotiations under the Inflation Reduction Act.
Read more
2023-05-24 (informa.com)
Medicaid ‘Price Verification’ Audit Proposal Aims To Promote Cell, Gene Therapy Rebate Concessions
CMS proposed rule impact may be ‘modest’ but is framed as ensuring patient access to cutting edge treatments by helping to control Medicaid spending. Biden administration initiative also aims to address misclassification of brand drugs, duplicative 340B discounts, and PBM spread pricing.
Read more
2023-02-10 (commondreams.org)
Stop the War's Iraq Demonstration 20 Years on
Stop the War Coalition will be marking the 20th anniversary of the largest demonstration in British history on 15 February 2023. On this day over a million protestors took to the streets of London to join the Stop the War protest and oppose the Iraq war.
Read more
2017-08-18 (cnn.com)
Pediatricians say Florida hurt sick kids to help big GOP donors
Pediatricians question whether Florida's health department dumped sick kids off a special Medicaid insurance plan to help big GOP donors.
Read more
(beckershospitalreview.com)
4 developments in sepsis care in 2023
CMS and the Biden administration have set standards to improve sepsis care in hospitals, and researchers are pushing ahead with tools to help.
Read more
(beckershospitalreview.com)
4 developments in sepsis care in 2023
CMS and the Biden administration have set standards to improve sepsis care in hospitals, and researchers are pushing ahead with tools to help.
Read more